Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA

PURPOSE: This study examined 2-year outcome of consecutive therapy using entecavir (ETV) followed by telbivudine (LdT) in subjects with undetectable hepatitis B virus (HBV) DNA level and normal alanine aminotransferase level after the initial 6 months of ETV treatment. MATERIALS AND METHODS: Sixty s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Yonsei Med J
Autori principali: Kim, Dong Hyun, Choi, Jong Won, Seo, Jeong Hun, Cho, Yong Suk, Won, Sun Young, Park, Byung Kyu, Jeon, Han Ho, Shin, Sang Yun, Lee, Chun Kyon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Yonsei University College of Medicine 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5368140/
https://ncbi.nlm.nih.gov/pubmed/28332360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.3.552
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi